Clinical Trials Browser

Phase 2 × Emapalumab × 1 year × Clear all

NCT06430788 2025-12-17

A Study of Emapalumab for Pediatric Aplastic Anemia

Phase 2 Recruiting

Classical hematology

Bone Marrow Failure Disorders, Cytopenia, Anemia, Aplastic

NCT06550141 2025-11-14

Emapalumab Prevention of CAR-T Cell Associated Toxicities

Phase 2 Recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse